No, Beat HF 7.5 Tablet is not a beta-blocker. It lowers the heart rate by selectively blocking the sodium channel present in heart pacemaker cells responsible for the increase in the heart rate.

Prescription Required

Marketer

Emcure Pharmaceuticals Ltd

SALT COMPOSITION

Ivabradine (7.5mg)

Click here to view all substitutes

Product introduction

Beat HF 7.5 Tablet is a medicine used for the treatment of angina (heart-related chest pain) and chronic (long-term) heart failure. It makes the heart work more efficiently by lowering the heart rate. This relieves chest pain and decreases the risk of hospitalization in heart failure patients.

Beat HF 7.5 Tablet is a medicine used for treatment of angina (heart-related chest pain) and chronic (long-term) heart failure. It makes the heart work more efficiently by lowering the heart rate. This relieves chest pain and decreases risk of hospitalization in heart failure patients. It must be taken with food. It may cause bradycardia (low heart rate) as a side effect. Hence, the heart rate should be monitored while using this medicine.

Uses of Beat HF Tablet

Benefits of Beat HF Tablet

In Treatment of Angina (heart-related chest pain)

Beat HF 7.5 Tablet is a heart rate lowering medication. It works by slowing down your heart rate. This lowers the heart’s need for oxygen, making it less likely that you will suffer chest pain. The medicine can reduce the frequency of angina attacks and help increase your ability to exercise and go about your daily life more efficiently. You should not stop taking it without your doctor’s advice, even if you feel well.

In Treatment of Heart failure

Heart failure is a condition where your heart cannot pump enough blood to the rest of your body. Beat HF 7.5 Tablet can be used in combination with other medicines to improve symptoms such as breathlessness, tiredness, and swelling and prevent heart failure from getting worse. This will improve your quality of life, allow you to go about your daily activities more easily, and decreases the risk of hospitalization in heart failure patients. This medicine needs to be taken regularly to be effective. Do not stop taking it until the doctor tells you so, even if you feel well.

show less

Side effects of Beat HF Tablet

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Beat HF

Slow heart rate
Luminous phenomena (Enhanced brightness)
High blood pressure
Atrial fibrillation
Dizziness
Blurred vision
ECG changes

How to use Beat HF Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Beat HF 7.5 Tablet is to be taken with food.

How Beat HF Tablet works

Beat HF 7.5 Tablet is a heart rate lowering medication. It works by reducing the heart rate which lowers the oxygen requirement of the heart. As a result, the heart works more efficiently.

Safety advice

Alcohol

CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Beat HF 7.5 Tablet. Please consult your doctor.

Pregnancy

UNSAFE

Beat HF 7.5 Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.

Breast feeding

UNSAFE

Beat HF 7.5 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.

Driving

UNSAFE

Beat HF 7.5 Tablet may cause side effects which could affect your ability to drive.
Beat HF 7.5 Tablet may cause transient luminous phenomena consisting mainly of phosphenes. The possible occurrence of such luminous phenomena should be taken into account especially when driving at night.

Kidney

CAUTION

Beat HF 7.5 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Beat HF 7.5 Tablet may be needed. Please consult your doctor.
Limited information is available for use of Beat HF 7.5 Tablet in patients with severe kidney disease.

Liver

CAUTION

Beat HF 7.5 Tablet should be used with caution in patients with liver disease. Dose adjustment of Beat HF 7.5 Tablet may be needed. Please consult your doctor.
Use of Beat HF 7.5 Tablet is not recommended in patients with severe liver disease.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Beat HF 7.5 Tablet

₹7.5/Tablet

Coralan 7.5mg Tablet

Serdia Pharmaceuticals India Pvt Ltd

₹25/tablet

233% costlier

Ivazine 7.5mg Tablet

Torrent Pharmaceuticals Ltd

₹11.6/tablet

55% costlier

Ivables 7.5 Tablet

Lloyd Healthcare Pvt Ltd

₹7.45/tablet

1% cheaper

Ivangin 7.5mg Tablet

Zydus Cadila

₹7.43/tablet

1% cheaper

Ivabrad 7.5 Tablet

Lupin Ltd

₹29.14/tablet

289% costlier

View all substitutes

Quick tips

Beat HF 7.5 Tablet may cause dizziness or sleepiness. Do not drive or do anything requiring concentration until you know how it affects you.
You may experience temporary changes in your vision such as enhanced visual brightness. These changes may occur within the initial 2 months of treatment and should gradually go away.
Monitor your blood pressure when taking Beat HF 7.5 Tablet as it can increase your blood pressure.
Monitor your heart rate when taking this medicine, as low heart rate is a common side effect. Inform your doctor if you experience symptoms of low heart rate such as dizziness, tiredness and low energy.

Fact Box

Chemical Class

Benzazepine derivative

Habit Forming

Therapeutic Class

CARDIAC

Action Class

I F sodium channel (sinoatrial node) current blockers

Patient concerns

What is heart attack? When heart attack coming?

Dr. Nabajit Talukdar

Interventional Cardiology

Related to chest pain angina commonly

Chest pain, improper heart beat

Dr. Nabajit Talukdar

Interventional Cardiology

Get 24 hrs holter done

FAQs

What type of drug is Beat HF 7.5 Tablet?

Beat HF 7.5 Tablet is a heart medicine. It belongs to a class of medicine known as hyperpolarization-activated cyclic nucleotide-gated (HCN) channel blockers. It works by slowing the heart rate. This helps the heart to pump more blood through the body each time it beats.

Does Beat HF 7.5 Tablet affect vision?

Beat HF 7.5 Tablet may cause temporary brightness in the field of vision (luminous visual phenomena). This usually disappears with continuous use of Beat HF 7.5 Tablet. If this happens to you, be careful when driving or using machines at times when there could be sudden changes in light intensity, especially when driving at night.

What are the symptoms of overdosage of Beat HF 7.5 Tablet?

The symptoms of overdosage of Beat HF 7.5 Tablet include slow heartbeat, dizziness, excessive tiredness and lack of energy. If you have taken higher than the recommended dose or experience any of these, consult your doctor immediately or seek emergency medical attention.

What is the most important information that I should know about Beat HF 7.5 Tablet?

You should remember that Beat HF 7.5 Tablet may cause serious side effects in adults and children. Its use in pregnant women can harm the unborn baby. Some of the other serious side effects may include increased risk of irregular or rapid heartbeat (atrial fibrillation or heart rhythm problems) and slower than normal heart rate (bradycardia).

Does Beat HF 7.5 Tablet lower blood pressure?

No, Beat HF 7.5 Tablet commonly causes an increase in blood pressure as a side effect. This change is temporary and does not affect the treatment with Beat HF 7.5 Tablet. However, it should not be given to patients with severely low blood pressure (blood pressure < 90/50 mmHg).

Is Beat HF 7.5 Tablet a beta-blocker?

No, Beat HF 7.5 Tablet is not a beta-blocker. It lowers the heart rate by selectively blocking the sodium channel present in heart pacemaker cells responsible for the increase in the heart rate.

Show less

Related ayurvedic ingredients

Fish Oil

Arjuna

Top Cardiologists

Dr. Manjinder Sandhu

MBBS, MD, DNB, DM, Fellowship, Fellowship

4.7 ★

Dr. Balbir Singh

MBBS, MD, DM, Fellowship, Fellowship

4.8 ★

Dr. R. R. Kasliwal

MBBS, MD, DM, Fellowship

4.7 ★

Dr. Dhananjay Kumar Jhamb

MBBS, MD, DM

4.7 ★

Dr. Monik Mehta

MBBS, MD, DM, Fellowship

4.5 ★

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Opie LH, Horowitz JD. Nitrates and Newer Antianginals β-Blocking Agents. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. p. 57.
Katzung BG, Chatterjee K. Vasodilator & the Treatment of Angina Pectoris. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 203-204.
Central Drugs Standard Control Organisation (CDSCO). [Accessed 19 Mar. 2019] (online) Available from:
Ivabradine [Package Insert]. Solan, Himachal Pradesh: Hetero Labs Limited (Unit II); 2023. [Accessed 07 Jul. 2023]. (online) Available from:

Marketer details

Name: Emcure Pharmaceuticals Ltd

Address: 255/2, Hinjawadi, Pune - 411057, India

Country of origin: India

The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.